Detalles de la búsqueda
1.
Real-world outcomes, treatment patterns and T790M testing rates in non-small cell lung cancer patients treated with first-line first- or second-generation epidermal growth factor receptor tyrosine kinase inhibitors from the Slovenian cohort of the REFLECT study.
Radiol Oncol
; 56(3): 371-379, 2022 08 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-35853681
Resultados
1 -
1
de 1
1
Próxima >
>>